Low-dose thioperamide injected into the cerebellar vermis of mice immediately after exposure to the elevated plus-maze impairs their avoidance behavior on re-exposure to the apparatus
Authors:
Open Access
- 1 October 2013
- journal article
- biomedical sciences
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 46 (11) , 943-948
Abstract
The present study investigated the effect of thioperamide (THIO), an H3 histaminergic receptor antagonist, microinjected into the cerebellar vermis on emotional memory consolidation in male Swiss albino mice re-exposed to the elevated plus-maze (EPM). We implanted a guide cannula into the cerebellar vermis using stereotactic surgery. On the third day after surgery, we performed behavioral tests for two consecutive days. On the first day (exposure), the mice (n=10/group) were exposed to the EPM and received THIO (0.06, 0.3, or 1.5 ng/0.1 µL) immediately after the end of the session. Twenty-four hours later, the mice were re-exposed to the EPM under the same experimental conditions, but without drug injection. A reduction in the exploration of the open arms upon re-exposure to the EPM (percentage of number of entries and time spent in open arms) compared with the initial exposure was used as an indicator of learning and memory. One-way analysis of variance (ANOVA) followed by the Duncan post hoc test was used to analyze the data. Upon re-exposure, exploratory activity in the open arms was reduced in the control group, and with the two highest THIO doses: 0.3 and 1.5 ng/0.1 µL. No reduction was seen with the lowest THIO dose (0.06 ng/0.1 µL), indicating inhibition of the consolidation of emotional memory. None of the doses interfered with the animals' locomotor activity. We conclude that THIO at the lowest dose (0.06 ng/0.1 µL) microinjected into the cerebellum impaired emotional memory consolidation in mice.Keywords
This publication has 19 references indexed in Scilit:
- The prototypical histamine H3 receptor inverse agonist thioperamide improves multiple aspects of memory processing in an inhibitory avoidance taskBehavioural Brain Research, 2013
- The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H3 Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary InvestigationCurrent Alzheimer Research, 2013
- Microinjection of histamine into the cerebellar vermis impairs emotional memory consolidation in miceBrain Research Bulletin, 2011
- L-histidine provokes a state-dependent memory retrieval deficit in mice re-exposed to the elevated plus-mazeBrazilian Journal of Medical and Biological Research, 2010
- The role of histamine on cognitionBehavioural Brain Research, 2009
- The role of histamine and the tuberomamillary nucleus in the nervous systemNature Reviews Neuroscience, 2003
- Cerebellar role in fear-conditioning consolidationProceedings of the National Academy of Sciences, 2002
- Histamine H3-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition taskBehavioural Brain Research, 2001
- Molecular pharmacological aspects of histamine receptorsPharmacology & Therapeutics, 1995
- The interplay of learning and anxiety in the elevated plus-mazeBehavioural Brain Research, 1993